title: A two-pronged attack against mantle cell lymphoma.
abstract: In this issue of Blood, Bhatt et al describe direct cytotoxic and indirect immune cell-mediated effects of interleukin-21 (IL-21) in mantle cell lymphoma (MCL), providing a preclinical rationale for IL-21 therapy in this aggressive disease.
authors.affiliation: BRITISH COLUMBIA CANCER AGENCY.
authors.forename: Christian
authors.identifier: http://orcid.org/0000-0001-9842-9750
authors.initials: C
authors.lastname: Steidl
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology* / Q000627:therapeutic use*; D007378:Interleukins / Q000276:immunology* / Q000627:therapeutic use*; D020522:Lymphoma, Mantle-Cell / Q000276:immunology* / Q000628:therapy*
chemical_list: D007155:Immunologic Factors; D007378:Interleukins